当前位置:首页 - 行情中心 - 天新药业(603235) - 财务分析 - 现金流量表

天新药业

(603235)

  

流通市值:112.07亿  总市值:112.07亿
流通股本:4.38亿   总股本:4.38亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金592,199,524.632,058,045,632.271,526,360,406.881,038,942,294.14
  收到的税费返还8,090,995.3628,772,892.6633,714,806.0732,510,657.25
  收到其他与经营活动有关的现金9,868,736.3149,248,954.4630,965,924.9219,626,775.89
  经营活动现金流入小计610,159,256.32,136,067,479.391,591,041,137.871,091,079,727.28
  购买商品、接受劳务支付的现金231,084,240.72846,022,401.42602,565,918.36396,775,058.03
  支付给职工以及为职工支付的现金184,376,770.1429,395,232.29328,102,258.66247,736,143.65
  支付的各项税费45,148,447.77174,588,756.83127,272,810.2981,958,770.73
  支付其他与经营活动有关的现金12,663,507.8456,698,591.1842,549,971.4722,612,055.52
  经营活动现金流出小计473,272,966.431,506,704,981.721,100,490,958.78749,082,027.93
  经营活动产生的现金流量净额136,886,289.87629,362,497.67490,550,179.09341,997,699.35
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额-569,597.2817,159.2917,159.29
  收到的其他与投资活动有关的现金651,545,252.85,188,937,358.523,894,923,679.043,072,534,586.45
  投资活动现金流入小计651,545,252.85,189,506,955.83,894,940,838.333,072,551,745.74
  购建固定资产、无形资产和其他长期资产支付的现金131,555,197.73580,681,982.02484,625,516.62350,955,383.99
  支付其他与投资活动有关的现金925,000,0004,698,322,0003,564,323,1882,744,322,000
  投资活动现金流出小计1,056,555,197.735,279,003,982.024,048,948,704.623,095,277,383.99
  投资活动产生的现金流量净额-405,009,944.93-89,497,026.22-154,007,866.29-22,725,638.25
三、筹资活动产生的现金流量:
  取得借款收到的现金7,414,058.5262,407,180.6241,826,693.3202,488,961.17
  收到其他与筹资活动有关的现金-13,982,844.7810,366,596.126,700,900
  筹资活动现金流入小计7,414,058.5276,390,025.38252,193,289.42209,189,861.17
  偿还债务支付的现金-7,634,940.251,000,0001,000,000
  分配股利、利润或偿付利息支付的现金2,462,304.27304,816,438.78301,900,354.65281,143,071.96
  支付其他与筹资活动有关的现金-3,524,391.08-1,710,058.46
  筹资活动现金流出小计2,462,304.27315,975,770.11302,900,354.65283,853,130.42
  筹资活动产生的现金流量净额4,951,754.23-39,585,744.73-50,707,065.23-74,663,269.25
四、汇率变动对现金及现金等价物的影响-14,170,073.49-8,967,062.683,384,890.89,695,228.44
五、现金及现金等价物净增加额-277,341,974.32491,312,664.04289,220,138.37254,304,020.29
  加:期初现金及现金等价物余额1,569,641,761.861,078,267,195.811,078,267,195.811,078,267,195.81
  期末现金及现金等价物余额1,292,299,787.541,569,579,859.851,367,487,334.181,332,571,216.1
补充资料:
  净利润-591,578,911.11-356,013,549.3
  资产减值准备-17,342,319.31-14,004,087.93
  固定资产和投资性房地产折旧-181,760,101.41-84,746,908.05
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-181,760,101.41-84,746,908.05
  无形资产摊销-4,659,540.14-2,282,689.98
  长期待摊费用摊销-2,489,201.16-918,032.19
  处置固定资产、无形资产和其他长期资产的损失-505,168.85-10,296.5
  固定资产报废损失-987,051.84-49,171.52
  公允价值变动损失----465,538.02
  财务费用-10,924,968.87--8,991,427.39
  投资损失--8,927,337.52--4,121,010.46
  递延所得税--7,723,871.97-2,108,248.23
  其中:递延所得税资产减少--7,723,871.97-2,108,248.23
  存货的减少--3,357,615--15,086,943.35
  经营性应收项目的减少--194,392,937.33-25,604,109.12
  经营性应付项目的增加-24,622,560--97,298,977.93
  其他-4,968,011.54--18,182,262.18
  现金的期末余额-1,569,579,859.85-1,332,571,216.1
  减:现金的期初余额-1,078,267,195.81-1,078,267,195.81
  现金及现金等价物的净增加额-491,312,664.04-254,304,020.29
公告日期2026-04-302026-04-242025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑